Friedrich-Alexander Ludwig

11PUBLICATIONS
30CO-AUTHORS
Sensory systemsCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromoleculesMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 13, 2025
A Full-Spectrum Evaluation of Sigma-1 Receptor (S1R) Positron Emission Tomography (PET) Radioligands from Binding Affinity to Clinical Imaging.

Francesco Mastropasqua, Friedrich-Alexander Ludwig, Carmen Abate

|Mar 26, 2025
Development of [99mTc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer.

Christian Lis, Friedrich-Alexander Ludwig, Steffen Fischer

|Dec 23, 2024
Development and evaluation of deuterated [18F]JHU94620 isotopologues for the non-invasive assessment of the cannabinoid type 2 receptor in brain.

Daniel Gündel, Mudasir Maqbool, Rodrigo Teodoro

|Feb 24, 2024
[18F]Fluspidine-A PET Tracer for Imaging of σ1 Receptors in the Central Nervous System.

Friedrich-Alexander Ludwig, Erik Laurini, Judith Schmidt

|Apr 12, 2022
A Pharmacokinetic and Metabolism Study of the TRPC6 Inhibitor SH045 in Mice by LC-MS/MS.

Xiao-Ning Chai, Friedrich-Alexander Ludwig, Anne Müglitz

|Mar 26, 2022
Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [18F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain.

Oliver Clauß, Linda Schäker-Hübner, Barbara Wenzel

Pageof 2

Frequent Collaborators

7 joint publications

Winnie Deuther-Conrad

7 joint publications

Peter Brust

6 joint publications

Magali Toussaint

6 joint publications

Daniel Gündel